Page last updated: 2024-08-23

n-(2-hydroxypropyl)methacrylamide and Peritoneal Carcinomatosis

n-(2-hydroxypropyl)methacrylamide has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briggs, SS; Chandler, L; Fisher, KD; Green, NK; Hale, S; Mautner, V; Morrison, J; Seymour, LW; Stevenson, M; Subr, V; Ulbrich, K1

Other Studies

1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Peritoneal Carcinomatosis

ArticleYear
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
    The journal of gene medicine, 2008, Volume: 10, Issue:3

    Topics: Acrylamides; Adenoviridae; Animals; Antibodies, Monoclonal; Female; Genetic Therapy; Genetic Vectors; Humans; Mice; Ovarian Neoplasms; Peritoneal Neoplasms; Polymers; Receptors, Fibroblast Growth Factor; Transduction, Genetic; Transgenes; Tumor Cells, Cultured

2008